{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:16:48Z","timestamp":1792001808931,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873611"],"award-info":[{"award-number":["81873611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700633"],"award-info":[{"award-number":["81700633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Innovation Team of Henan","award":["17IRTSTHN020"],"award-info":[{"award-number":["17IRTSTHN020"]}]},{"name":"Foundation for Leading Personnel\u00a0of Central Plains of China","award":["194200510006"],"award-info":[{"award-number":["194200510006"]}]},{"name":"Medical Science and Technology Public Relations Plan of Henan","award":["LHGJ20190241"],"award-info":[{"award-number":["LHGJ20190241"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Membranous nephropathy (MN) and minimal change disease (MCD) are two common causes leading to nephrotic syndrome (NS). They have similar clinical features but different treatment strategies and prognoses. M-type phospholipase A2 receptor (PLA2R) is considered as a specific marker of membranous nephropathy. However, its sensitivity is only about 70%. Therefore, there is a lack of effective and noninvasive tools to distinguish PLA2R-negative MN and MCD patients without renal biopsy. A total 949 patients who were pathologically diagnosed as idiopathic MN or MCD were enrolled in this study, including 805 idiopathic MN and 144 MCD. Based on the basic information and laboratory examination of 200 PLA2R-negative MN and 144 MCD, we used a univariate and multivariate logistic regression to select the relevant variables and develop a discrimination model. A novel model including age, albumin, urea, high density lipoprotein, C3 levels and red blood cell count was established for PLA2R-negative MN and MCD. The discrimination model has great differential capability (with an AUC of 0.904 in training group and an AUC of 0.886 in test group) and calibration capability. When testing in all 949 patients, our model also showed good discrimination ability for all idiopathic MN and MCD. <\/jats:p>","DOI":"10.1038\/s41598-021-97517-8","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T10:03:22Z","timestamp":1631268202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy"],"prefix":"10.1038","volume":"11","author":[{"given":"Feng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"97517_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/0886022x.2016.1183443","volume":"38","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Analysis of 4931 renal biopsy data in central China from 1994 to 2014. Ren. Fail. 38, 1021\u20131030. https:\/\/doi.org\/10.1080\/0886022x.2016.1183443 (2016).","journal-title":"Ren. Fail."},{"key":"97517_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4103\/0366-6999.226906","volume":"131","author":"Y Yang","year":"2018","unstructured":"Yang, Y., Zhang, Z., Zhuo, L., Chen, D. & Li, W. The spectrum of biopsy-proven glomerular disease in China: A systematic review. Chin. Med. J. 131, 731\u2013735. https:\/\/doi.org\/10.4103\/0366-6999.226906 (2018).","journal-title":"Chin. Med. J."},{"key":"97517_CR3","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1038\/s41598-020-67910-w","volume":"10","author":"R Hu","year":"2020","unstructured":"Hu, R. et al. Spectrum of biopsy proven renal diseases in Central China: A 10-year retrospective study based on 34, 630 cases. Sci. Rep. 10, 10994. https:\/\/doi.org\/10.1038\/s41598-020-67910-w (2020).","journal-title":"Sci. Rep."},{"key":"97517_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/nep.13061","volume":"23","author":"J Ng","year":"2018","unstructured":"Ng, J. et al. Nephrology (Carlton) 23, 565\u2013572. https:\/\/doi.org\/10.1111\/nep.13061 (2018).","journal-title":"Nephrology (Carlton)"},{"key":"97517_CR5","doi-asserted-by":"crossref","unstructured":"Clinical competence in percutaneous renal biopsy. Health and Public Policy Committee. American College of Physicians. Ann. Intern. Med. 108, 301\u2013303 (1988).","DOI":"10.7326\/0003-4819-108-2-301"},{"key":"97517_CR6","doi-asserted-by":"publisher","first-page":"8803","DOI":"10.1038\/srep08803","volume":"5","author":"H Dai","year":"2015","unstructured":"Dai, H., Zhang, H. & He, Y. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: An updated meta-analysis. Sci. Rep. 5, 8803. https:\/\/doi.org\/10.1038\/srep08803 (2015).","journal-title":"Sci. Rep."},{"key":"97517_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40620-017-0451-5","volume":"31","author":"A Radice","year":"2018","unstructured":"Radice, A. et al. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. J. Nephrol. 31, 271\u2013278. https:\/\/doi.org\/10.1007\/s40620-017-0451-5 (2018).","journal-title":"J. Nephrol."},{"key":"97517_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104936","volume":"9","author":"Y Du","year":"2014","unstructured":"Du, Y. et al. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: A meta-analysis. PLoS ONE 9, e104936. https:\/\/doi.org\/10.1371\/journal.pone.0104936 (2014).","journal-title":"PLoS ONE"},{"key":"97517_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/143274","volume":"2014","author":"A Behnert","year":"2014","unstructured":"Behnert, A. et al. Antiphospholipase A2 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J. Immunol. Res. 2014, 143274. https:\/\/doi.org\/10.1155\/2014\/143274 (2014).","journal-title":"J. Immunol. Res."},{"key":"97517_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/1724600819882698","volume":"34","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Clinicopathological features in membranous nephropathy with cancer: A retrospective single-center study and literature review. Int. J. Biol. Markers 34, 406\u2013413. https:\/\/doi.org\/10.1177\/1724600819882698 (2019).","journal-title":"Int. J. Biol. Markers"},{"key":"97517_CR11","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 12, 1642\u20131651. https:\/\/doi.org\/10.2215\/CJN.01460217 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"97517_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","volume":"30","author":"S Sethi","year":"2019","unstructured":"Sethi, S. et al. Exostosin 1\/exostosin 2-associated membranous nephropathy. J. Am. Soc. Nephrol. 30, 1123\u20131136. https:\/\/doi.org\/10.1681\/ASN.2018080852 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"97517_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi, S. et al. Protocadherin 7-associated membranous nephropathy. J. Am. Soc. Nephrol. 32, 1249\u20131261. https:\/\/doi.org\/10.1681\/ASN.2020081165 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"97517_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Buuren","year":"2011","unstructured":"Buuren, S. & Groothuis-Oudshoorn, K. Mice: Multivariate imputation by chained equations in R. J Stat. Softw. 45, 1\u201367 (2011).","journal-title":"J Stat. Softw."},{"key":"97517_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers, A. J., Cronin, A. M., Elkin, E. B. & Gonen, M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak. 8, 53. https:\/\/doi.org\/10.1186\/1472-6947-8-53 (2008).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"97517_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3265\/Nefrologia.pre2013.Oct.12256","volume":"34","author":"A Segarra","year":"2014","unstructured":"Segarra, A. et al. Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome. Nefrologia 34, 46\u201352. https:\/\/doi.org\/10.3265\/Nefrologia.pre2013.Oct.12256 (2014).","journal-title":"Nefrologia"},{"key":"97517_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/ejhf.683","volume":"19","author":"J Ghadri","year":"2017","unstructured":"Ghadri, J. et al. A novel clinical score (InterTAK diagnostic score) to differentiate Takotsubo syndrome from acute coronary syndrome: Results from the International Takotsubo Registry. Eur. J. Heart Fail. 19, 1036\u20131042. https:\/\/doi.org\/10.1002\/ejhf.683 (2017).","journal-title":"Eur. J. Heart Fail."},{"key":"97517_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/hep.28002","volume":"62","author":"Y Kamada","year":"2015","unstructured":"Kamada, Y. et al. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology (Baltimore, MD) 62, 1433\u20131443. https:\/\/doi.org\/10.1002\/hep.28002 (2015).","journal-title":"Hepatology (Baltimore, MD)"},{"key":"97517_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000505145","volume":"51","author":"S Jiang","year":"2020","unstructured":"Jiang, S. et al. Novel model predicts diabetic nephropathy in type 2 diabetes. Am. J. Nephrol. 51, 130\u2013138. https:\/\/doi.org\/10.1159\/000505145 (2020).","journal-title":"Am. J. Nephrol."},{"key":"97517_CR20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8499","volume":"8","author":"L Sun","year":"2020","unstructured":"Sun, L., Shang, J., Xiao, J. & Zhao, Z. Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy. PeerJ 8, e8499. https:\/\/doi.org\/10.7717\/peerj.8499 (2020).","journal-title":"PeerJ"},{"key":"97517_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/0886022x.2020.1772294","volume":"42","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y., Shang, J., Liu, D., Xiao, J. & Zhao, Z. Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure. Ren. Fail. 42, 550\u2013559. https:\/\/doi.org\/10.1080\/0886022x.2020.1772294 (2020).","journal-title":"Ren. Fail."},{"key":"97517_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.23876\/j.krcp.19.077","volume":"39","author":"T Yim","year":"2020","unstructured":"Yim, T. et al. Patterns in renal diseases diagnosed by kidney biopsy: A single-center experience. Kidney Res. Clin. Pract. 39, 60\u201369. https:\/\/doi.org\/10.23876\/j.krcp.19.077 (2020).","journal-title":"Kidney Res. Clin. Pract."},{"key":"97517_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/0886022x.2018.1537930","volume":"40","author":"Q Zhou","year":"2018","unstructured":"Zhou, Q. et al. Changes in the diagnosis of glomerular diseases in east China: A 15-year renal biopsy study. Ren. Fail. 40, 657\u2013664. https:\/\/doi.org\/10.1080\/0886022x.2018.1537930 (2018).","journal-title":"Ren. Fail."},{"key":"97517_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000501857","volume":"143","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Antiphospholipid antibodies in patients with membranous nephropathy. Nephron 143, 228\u2013233. https:\/\/doi.org\/10.1159\/000501857 (2019).","journal-title":"Nephron"},{"key":"97517_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto, R. et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: The Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin. Exp. Nephrol. 24, 526\u2013540. https:\/\/doi.org\/10.1007\/s10157-020-01864-1 (2020).","journal-title":"Clin. Exp. Nephrol."},{"key":"97517_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/cjn.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman, M. et al. Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin. J. Am. Soc. Nephrol. (CJASN) 2, 445\u2013453. https:\/\/doi.org\/10.2215\/cjn.03531006 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol. (CJASN)"},{"key":"97517_CR27","doi-asserted-by":"publisher","first-page":"F579","DOI":"10.1152\/ajprenal.2001.281.4.F579","volume":"281","author":"W Deen","year":"2001","unstructured":"Deen, W., Lazzara, M. & Myers, B. Structural determinants of glomerular permeability. Am. J. Physiol. Renal Physiol. 281, F579-596. https:\/\/doi.org\/10.1152\/ajprenal.2001.281.4.F579 (2001).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"97517_CR28","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1097\/01.Asn.0000139478.03463.D9","volume":"15","author":"A Lahdenkari","year":"2004","unstructured":"Lahdenkari, A. et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J. Am. Soc. Nephrol. 15, 2611\u20132618. https:\/\/doi.org\/10.1097\/01.Asn.0000139478.03463.D9 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"97517_CR29","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1093\/ndt\/gfr136","volume":"26","author":"N Vaziri","year":"2011","unstructured":"Vaziri, N. et al. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor. Nephrol. Dial. Transplant. 26, 3118\u20133123. https:\/\/doi.org\/10.1093\/ndt\/gfr136 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"97517_CR30","first-page":"891","volume":"20","author":"T Fujita","year":"2006","unstructured":"Fujita, T. et al. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy. Vivo (Athens, Greece) 20, 891\u2013893 (2006).","journal-title":"Vivo (Athens, Greece)"},{"key":"97517_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12865-018-0254-z","volume":"19","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. BMC Immunol. 19, 18. https:\/\/doi.org\/10.1186\/s12865-018-0254-z (2018).","journal-title":"BMC Immunol."},{"key":"97517_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071812","author":"M Pekna","year":"2021","unstructured":"Pekna, M. & Pekny, M. The complement system: A powerful modulator and effector of astrocyte function in the healthy and diseased central nervous system. Cells https:\/\/doi.org\/10.3390\/cells10071812 (2021).","journal-title":"Cells"},{"key":"97517_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MNH.0000000000000705","volume":"30","author":"NR Medjeral-Thomas","year":"2021","unstructured":"Medjeral-Thomas, N. R., Pickering, M. C. & Cook, H. T. Complement and kidney disease, new insights. Curr. Opin. Nephrol. Hypertens. 30, 310\u2013316. https:\/\/doi.org\/10.1097\/MNH.0000000000000705 (2021).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"97517_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240566","volume":"15","author":"J Choi","year":"2020","unstructured":"Choi, J. et al. Idiopathic membranous nephropathy in older patients: Clinical features and outcomes. PLoS ONE 15, e0240566. https:\/\/doi.org\/10.1371\/journal.pone.0240566 (2020).","journal-title":"PLoS ONE"},{"key":"97517_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3904\/kjim.2018.139","volume":"34","author":"Y Kim","year":"2019","unstructured":"Kim, Y. et al. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy. Korean J. Intern. Med. 34, 1091\u20131099. https:\/\/doi.org\/10.3904\/kjim.2018.139 (2019).","journal-title":"Korean J. Intern. Med."},{"key":"97517_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/0886022x.2018.1455591","volume":"40","author":"P Chen","year":"2018","unstructured":"Chen, P. et al. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy. Ren. Fail. 40, 213\u2013218. https:\/\/doi.org\/10.1080\/0886022x.2018.1455591 (2018).","journal-title":"Ren. Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97517-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:30:05Z","timestamp":1670081405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97517-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97517"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97517-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"assertion":[{"value":"11 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18064"}}